80
Participants
Start Date
February 7, 2020
Primary Completion Date
September 30, 2024
Study Completion Date
December 31, 2027
Liraglutide 6 MG/ML [Victoza]
Starting dose of liraglutide 0.6 mg will be administered for one week, after which dose will be escalated to liraglutide 1.2 mg for one week and thereafter liraglutide 1.8 mg s.c. daily injections.
Placebos
Starting dose of placebo 0.1 ml will be administered for one week, after which dose will be escalated to placebo 0.2 ml for one week and thereafter placebo 0.3 ml s.c. daily injections.
Turku University Hospital, Turku
Turku University Hospital
OTHER_GOV